CN103393902A - Clinical-laboratory traumatic bactericidal inflammation-diminishing drug and preparation method thereof, - Google Patents
Clinical-laboratory traumatic bactericidal inflammation-diminishing drug and preparation method thereof, Download PDFInfo
- Publication number
- CN103393902A CN103393902A CN2013103349965A CN201310334996A CN103393902A CN 103393902 A CN103393902 A CN 103393902A CN 2013103349965 A CN2013103349965 A CN 2013103349965A CN 201310334996 A CN201310334996 A CN 201310334996A CN 103393902 A CN103393902 A CN 103393902A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- folium
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a clinical-laboratory traumatic bactericidal inflammation-diminishing drug and a preparation method thereof, the drug is prepared from effective components comprising the following raw materials: callicar pa nudiflora Hook. et Arn, magnolia officinalis, sambucus chinensis, honeysuckle, ganoderma lucidum, aloe leaf, radix angelicae pubescentis, radix zanthoxyli, purslane, dandelion, leptochloa chinensis, sweet wormwood, frankincense, astragalus, embelia laeta (L.) mez root and cortex ailanthi; the drug has the effects of dispelling wind-evil and relieving pains, clearing heat and removing toxicity, diminishing inflammation and killing bacterium, is suitable for bacterium killing and inflammation diminishing of traumatic wound specimen extraction in a clinical laboratory, and also can be used for skin and mucosa disinfection, skin trauma disinfection, and treatment of trichomonas vaginitis, colpitis mycotica, skin fungal infection and the like; the compatibility of the selected medicinal materials of the drug is appropriate, and the drug is prepared by use of a modern advanced pharmaceutical technology, is safe to use, has no stimulation and no side effects, can kill bacterium propagules, fungus, protozoon, and part of virus, and is worthy of wide use in the clinical laboratory.
Description
Technical field
The present invention relates to the field of Chinese medicines, particularly a kind of clinical laboratory's wound bactericidal antiphlogistic medicine and preparation method.
Background technology
Clinical laboratory is as the section office of hospital inspection chemical examination; often can extract specimen to some traumatic patients chemically examines; and the bactericidal antiphlogistic medicine that assay office uses such as iodine tincture, ethanol, povidone iodine etc. are mostly irritant to human body wound and skin; be unfavorable for wound healing; what have even can cause allergic reaction; if bactericidal antiphlogistic is not thorough, be easy to fester a wound, affect conditions of patients and take a turn for the better and live normally.
So,, for to traumatic patient, providing safety assurance, also for the personnel of clinical laboratory work, providing convenience, it is good and to the non-irritating medicine of skin that we need to find a kind of bactericidal anti-inflammatory effect, solves the problems referred to above.
Summary of the invention
The invention provides a kind of clinical laboratory wound bactericidal antiphlogistic medicine and preparation method, medicine of the present invention has wind-expelling pain-stopping, heat-clearing and toxic substances removing, the effect of antiphlogistic antibacterial, be applicable to the bactericidal antiphlogistic that clinical laboratory's trauma wounds specimen is extracted, also can be used for the sterilization of skin and mucosa, skin injury sterilization, treatment trichomonal vaginitis, colpitis mycotica, skin fungus infection etc.
For achieving the above object, technical scheme of the present invention is implemented as follows:
A kind of clinical laboratory wound bactericidal antiphlogistic medicine, raw material composition and the parts by weight of making described effective ingredient are:
Folium et Ramulus Callicarpae nudiflorae 45-85 part Cortex Magnoliae Officinalis 50-85 part Rhizoma seu Herba Elatostematis stewardii 60-90 part Flos Lonicerae 60-85 part
Ganoderma 10-20 part Folium Aloe 45-75 part Radix Angelicae Pubescentis 45-80 part Radix Zanthoxyli 35-75 part
Herba Portulacae 40-65 part Herba Taraxaci 40-85 part Semen Euphorbiae 35-65 part Herba Artemisiae Annuae 30-65 part
Olibanum 20-50 part Radix Malvae rotundifoliae 25-65 part Radix embeliae laetae 35-75 part Cortex Ailanthi 35-70 part.
Raw material composition and the parts by weight of making described effective ingredient are:
78 parts of 83 portions of Flos Loniceraes of 75 parts of Rhizoma seu Herba Elatostematis stewardiis of 75 parts of Cortex Magnoliae Officinalis of Folium et Ramulus Callicarpae nudiflorae
65 parts of 71 portions of Radix Zanthoxylis of 62 parts of Radix Angelicae Pubescentiss of 17 parts of Folium Aloes of Ganoderma
55 parts of 55 portions of Herba Artemisiae Annuaes of 70 parts of Semen Euphorbiaes of 55 parts of Herba Taraxacis of Herba Portulacae
60 parts of 65 parts of Cortex Ailanthis of 55 parts of Radix embeliae laetae of 45 parts of Radix Malvae rotundifoliaes of Olibanum.
Raw material composition and the parts by weight of making described effective ingredient are:
69 parts of 75 portions of Flos Loniceraes of 65 parts of Rhizoma seu Herba Elatostematis stewardiis of 65 parts of Cortex Magnoliae Officinalis of Folium et Ramulus Callicarpae nudiflorae
55 parts of 61 portions of Radix Zanthoxylis of 58 parts of Radix Angelicae Pubescentiss of 15 parts of Folium Aloes of Ganoderma
45 parts of 45 portions of Herba Artemisiae Annuaes of 60 parts of Semen Euphorbiaes of 50 parts of Herba Taraxacis of Herba Portulacae
50 parts of 55 parts of Cortex Ailanthis of 45 parts of Radix embeliae laetae of 35 parts of Radix Malvae rotundifoliaes of Olibanum.
Raw material composition and the parts by weight of making described effective ingredient are:
64 parts of 65 portions of Flos Loniceraes of 55 parts of Rhizoma seu Herba Elatostematis stewardiis of 55 parts of Cortex Magnoliae Officinalis of Folium et Ramulus Callicarpae nudiflorae
45 parts of 51 portions of Radix Zanthoxylis of 50 parts of Radix Angelicae Pubescentiss of 13 parts of Folium Aloes of Ganoderma
35 parts of 40 portions of Herba Artemisiae Annuaes of 50 parts of Semen Euphorbiaes of 45 parts of Herba Taraxacis of Herba Portulacae
40 parts of 45 parts of Cortex Ailanthis of 35 parts of Radix embeliae laetae of 25 parts of Radix Malvae rotundifoliaes of Olibanum.
The preparation method of a kind of clinical laboratory wound bactericidal antiphlogistic medicine comprises following processing step:
(1) get Folium et Ramulus Callicarpae nudiflorae, Cortex Magnoliae Officinalis, Flos Lonicerae, Herba Taraxaci and Cortex Ailanthi and clean, put into heating vessel, add 85% alcoholic solution of 4 times of amounts, heating and refluxing extraction 3-4 hour, filter, and obtains filtrate for later use;
(2) get Rhizoma seu Herba Elatostematis stewardii, Radix Angelicae Pubescentis, Semen Euphorbiae, Radix Malvae rotundifoliae and Radix embeliae laetae and clean, put into container, the distilled water that adds 8-12 doubly to measure, soaked after 4-5 hour, boils 3-4 hour, extracts; Again add 6-8 doubly to measure distilled water, boil 2-3 hour, extract; Finally, add 4-6 doubly to measure distilled water, heated and boiled 1-2 hour, extract; Merge three times extracting solution, filter, reserved filtrate is standby;
(3) get Herba Portulacae and Herba Artemisiae Annuae and clean, strand juice, filter, and obtains juice standby;
(4) get Olibanum, clean, while with slow fire, frying to surface melting, spray a small amount of rice vinegar, continue to fry to outer light, take out, cool, grind into powder, cross 200 order fine powders, standby;
(5) get Ganoderma, Folium Aloe and Radix Zanthoxyli, cleaning, drying, chopping, grind into powder, crosses 120 order fine powders, and is standby;
(6) filtrate that above-mentioned steps (1)-(5) are made, juice and fine powder mix, and add ancillary drug, utilize modern advanced pharmacy science and technology, make antiseptic solution, are described clinical laboratory wound bactericidal antiphlogistic medicine.
The property of medicine of the present invention's Chinese medicine used is as follows:
Folium et Ramulus Callicarpae nudiflorae: little hardship, property is flat.Hemostasis, antiinflammatory, blood stasis dispelling, pain relieving.Cure mainly hemorrhage that pneumorrhagia type leptospirosis, pulmonary tuberculosis, lung abscess, lobar pneumonia etc. cause, Peptic Ulcers etc." Nanning City's medicine will " carries: " hemostasis, pain relieving.Control traumatic injury, gunshot wound." the modern medicine confirmation, Folium et Ramulus Callicarpae nudiflorae has hemostasis, antibiotic and wind dispelling detumescence effect.
Cortex Magnoliae Officinalis: bitter in the mouth, suffering, warm in nature.Enter spleen, stomach, lung, large intestine channel.The modern medicine study confirmation, Cortex Magnoliae Officinalis has stronger antibacterial action to dysentery bacterium, escherichia coli, Bacillus typhi, and is stronger than Rhizoma Coptidis, Radix Scutellariae to the antibacterial action of staphylococcus aureus.
Rhizoma seu Herba Elatostematis stewardii: bitter in the mouth, property is flat.Promoting tissue regeneration by removing blood stasis, relaxing muscles and tendons and activating QI and blood in the collateral, strong muscles and bones, the dispelling the wind and dampness pathogens osteodynia, control traumatic injury, synthetism.Carry according to " the southern regions of the Yunnan Province book on Chinese herbal medicine ": " the row twelve channels and collaterals is controlled muscles and bones phlegm-fire, pain, numb hand and foot meciless.Loose scrofula brothers sucutaneous nodule, control traumatic injury, synthetism." modern medicine study confirms, the contained Quercetin of Rhizoma seu Herba Elatostematis stewardii, quercitrin, Isoquercitrin etc. have stronger inhibitory action to Staphylococcus aureus bacillus, Bacillus typhi, the contained obvious antiinflammatory action of hyperin tool.
Flos Lonicerae: sweet in the mouth, little hardship, cold in nature; Return lung, stomach, the heart, large intestine channel.Heat clearing away is eliminating evil, dispelling wind-heat, removing summer-heat blood poison.Modern pharmacological research shows, effective ingredient in Flos Lonicerae has antibiotic and antivirus action, staphylococcus aureus, Hemolytic streptococcus, dysentery bacterium, Bacillus typhi, meningococcus, Diplococcus pneumoniae, bacillus pyocyaneus and influenza virus etc. there is obvious inhibitory action, and can strengthen immunologic function, antiinflammatory, analgesic, have obvious inhibitory action to inflammation.
Ganoderma: sweet in the mouth, property is flat.GUIXIN, liver, spleen, lung, the kidney Five Classics.Cure mainly asthenia, cough, asthma, insomnia, dyspepsia, malignant tumor etc.Pharmacological evaluation shows, Ganoderma has inhibitory action to nervous system, and blood circulation is had blood pressure lowering and strengthens the effect of cardiac contractile force, and respiratory system is had phlegm-dispelling functions, in addition, also has hepatoprotective, improves immunologic function, antibioticly waits effect.
Folium Aloe: bitter in the mouth, puckery, property are flat.Pathogenic fire purging, detoxifcation, blood stasis dispelling, parasite killing.Argument is red, constipation, nebulousurine, hematuria, pediatric epilepsy scared, infantile malnutrition, burn and scald, women's amenorrhea, hemorrhoid, scabies, carbuncle furuncle and phyma poison, traumatic injury." the SHENGCAO property of medicine standby will " carries: " cooling blood and relieving pain.Control internal injury, wash hemorrhoid, apply the skin ulcer scabies, deoil greasy.”
Radix Angelicae Pubescentis: sweet in the mouth, slightly warm in nature, nontoxic, enter kidney, urinary bladder channel.Calmness, hypnosis, analgesia, antiinflammatory." property of medicine opinion " carries: " in controlling, all rheumatism is cold, the dyspnea gas of running quickly, and the musculus cutaneus hardship is itched, brothers' spasm and pain, strain, main air poison toothache." modern medicine study shows, Radix Angelicae Pubescentis has antiinflammatory, analgesia and sedation.
Radix Zanthoxyli: bitter in the mouth, suffering, property is flat, and is slightly poisonous; Return liver, stomach warp.Promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling, dispelling wind and removing obstruction in the collateral.Be used for traumatic injury, rheumatic arthralgia, stomachache, toothache that qi depression to blood stasis causes, venom, the burning hot wound of external treatment soup.Modern medicine study confirms, Radix Zanthoxyli is made powder, at topical therapeutic ulcer eliminate pain, promote the each side such as healing and Shorten the Treatment Process all to receive satisfied effect, and have antiinflammatory, analgesia, antitumor, an antifungal, regulate the effect of the aspects such as cardiovascular system, also have the pharmacological actions such as heart tonifying, blood pressure lowering.
Herba Portulacae: cold in nature, sweet in the mouth, acid; Enter the heart, liver, spleen, large intestine channel.Removing dampness is antipruritic, clearing heat for detumescence, heat-clearing and toxic substances removing, and diuretic dries, loose blood detumescence, dust-collection sterilization, anti-inflammatory analgetic, hemostasis removing heat from blood.The modern medicine study confirmation, Herba Portulacae has stronger inhibitory action to dysentery bacterium, Bacillus typhi and escherichia coli, can be used for the auxiliary treatment of various inflammation, have the title of " natural antibiotics ".
Herba Taraxaci: sweet in the mouth, little hardship, cold in nature.Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.Can be used for temperature disease, removing heat from the liver, treatment liver-heat conjunctival congestion and swelling pain, and multi-infection, purulent disease.Modern medicine study confirms, Herba Taraxaci has stronger bactericidal action to staphylococcus aureus resistance bacterial strain, Hemolytic streptococcus, and Diplococcus pneumoniae, meningococcus, diphtheria corynebacterium, bacillus pyocyaneus, Bacillus proteus, dysentery bacterium, Bacillus typhi etc. and micrococcus catarrhalis are also had certain bactericidal action.
Semen Euphorbiae: acrid in the mouth, warm in nature, poisonous, return liver, kidney, large intestine channel; The detumescence of relieving oedema or abdominal distension through diuresis or purgation, the removing blood stasis eliminating mass.Be used for edema, phlegm retention, stagnant distension, constipation and anuresis, blood stasis amenorrhea; The external treatment stubborn dermatitis, warty vegetation.The modern medicine study confirmation, the daphnetin that Semen Euphorbiae includes has inhibitory action to the growth of staphylococcus aureus, escherichia coli, shigella flexneri and bacillus pyocyaneus.
Herba Artemisiae Annuae: bitter in the mouth, suffering, cold in nature; Return liver, gallbladder, three warmers, kidney channel.Clear deficiency-heat thoroughly, removing heat from blood is except steaming, preventing the attack (or recurrence) of malaria.Be used for the pathogenic summer-heat heating, fever due to yin deficiency, night fever abating at dawn, hectic fever due to YIN-deficiency consumptive fever, malaria cold and heat, jaundice due to damp-heat.The modern medicine study confirmation, Herba Artemisiae Annuae has stronger bacteriostasis to staphylococcus epidermidis, micrococcus catarrhalis, anthrax bacillus, diphtheria corynebacterium, and staphylococcus aureus, bacillus pyocyaneus, dysentery bacterium, tuberculosis stalk bacterium etc. are also had certain inhibitory action.
Olibanum: acrid in the mouth, hardship, slightly warm in nature.Enter the heart, liver, spleen channel.Regulating qi and activating blood, analgesic therapy, chase after poison.Cure mainly coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury, dysmenorrhea, blood stasis twinge." detailed outline " carries: " all poison of eliminating carbuncle cellulitis, the heart is protected in Tuoli, and the analgesic therapy of invigorating blood circulation, stretch muscle." the modern medicine study confirmation, Olibanum volatile oil has analgesic activity, can promote polynuclear leucocyte to increase, and engulfs dead blood cell and cell, improves metabolism, and the antiinflammatory antisepsis is arranged.
Radix Malvae rotundifoliae: sweet in the mouth, warm in nature." Shaanxi Chinese herbal medicine " carries: " invigorating the spleen and replenishing QI, holder sore, diuresis, lactogenesis.Control asthenia, anemia, pulmonary tuberculosis, proctoptosis, uterine prolapse, oedema due to nephritis, diabetes, skin ulcer is swollen to be difficult for passing through inside, hypogalactia." modern medicine study confirms, the extract of Radix Malvae rotundifoliae root suppresses tubercule bacillus external.
Radix embeliae laetae: sour in the mouth is puckery, cool in nature.Heat-clearing and toxic substances removing, the dissipating blood stasis hemostasis.Main pharyngitis, gingiva bleeding gingival hemorrhage, dysentery, have loose bowels, furuncle ulcer, skin pruritus, swelling and pain of hemorrhoid, traumatic injury." Nanning City's medicine will " carries: " parasite killing, detumescence, help digestion.External treatment traumatic injury skin infection, rotten skin ulcer.”
Cortex Ailanthi: bitter in the mouth, puckery, cold in nature.Return stomach, large intestine, the heart, liver, spleen, lung meridian.Heat clearing and damp drying, astringing intestine to stop diarrhea, hemostasis, leukorrhagia stopping, parasite killing.Cure mainly and have loose bowels, dysentery, have blood in stool, metrorrhagia, bleeding hemorrhoids, leukorrhagia, ascariasis, skin ulcer tinea.The modern medicine study confirmation, the Cortex Ailanthi decoct has obvious inhibitory action to shigella flexneri, Song's Shigella flexneri and escherichia coli.
The present invention compared with prior art, has following beneficial effect:
1, medicine of the present invention has wind-expelling pain-stopping, heat-clearing and toxic substances removing, the effect of antiphlogistic antibacterial, be applicable to the bactericidal antiphlogistic that clinical laboratory's trauma wounds specimen is extracted, also can be used for the sterilization of skin and mucosa, skin injury sterilization, treatment trichomonal vaginitis, colpitis mycotica, skin fungus infection etc.
2, the selected medical material compatibility of medicine of the present invention is suitable, and adopts modern advanced medical pharmaceutical technology to make, and uses safety, and is non-stimulated, have no side effect, but kill vegetative forms of bacteria, fungus, protozoon and part virus, in clinical laboratory's application that should be widely promoted.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is further elaborated.
Embodiment 1
The raw material of effective ingredient of the present invention forms and weight is:
Folium et Ramulus Callicarpae nudiflorae 80g Cortex Magnoliae Officinalis 80g Rhizoma seu Herba Elatostematis stewardii 88g Flos Lonicerae 83g
Ganoderma 19g Folium Aloe 70g Radix Angelicae Pubescentis 78g Radix Zanthoxyli 70g
Herba Portulacae 60g Herba Taraxaci 80g Semen Euphorbiae 60g Herba Artemisiae Annuae 60g
Olibanum 48g Radix Malvae rotundifoliae 60g Radix embeliae laetae 70g Cortex Ailanthi 65g.
The preparation method of medicine of the present invention comprises following processing step:
(1) get Folium et Ramulus Callicarpae nudiflorae, Cortex Magnoliae Officinalis, Flos Lonicerae, Herba Taraxaci and Cortex Ailanthi and clean, put into heating vessel, add 85% alcoholic solution of 4 times of amounts, heating and refluxing extraction 3-4 hour, filter, and obtains filtrate for later use;
(2) get Rhizoma seu Herba Elatostematis stewardii, Radix Angelicae Pubescentis, Semen Euphorbiae, Radix Malvae rotundifoliae and Radix embeliae laetae and clean, put into container, the distilled water that adds 8-12 doubly to measure, soaked after 4-5 hour, boils 3-4 hour, extracts; Again add 6-8 doubly to measure distilled water, boil 2-3 hour, extract; Finally, add 4-6 doubly to measure distilled water, heated and boiled 1-2 hour, extract; Merge three times extracting solution, filter, reserved filtrate is standby;
(3) get Herba Portulacae and Herba Artemisiae Annuae and clean, strand juice, filter, and obtains juice standby;
(4) get Olibanum, clean, while with slow fire, frying to surface melting, spray a small amount of rice vinegar, continue to fry to outer light, take out, cool, grind into powder, cross 200 order fine powders, standby;
(5) get Ganoderma, Folium Aloe and Radix Zanthoxyli, cleaning, drying, chopping, grind into powder, crosses 120 order fine powders, and is standby;
(6) filtrate that above-mentioned steps (1)-(5) are made, juice and fine powder mix, and add ancillary drug, utilize modern advanced pharmacy science and technology, make antiseptic solution, are described clinical laboratory wound bactericidal antiphlogistic medicine.
Usage and dosage: external, medicine is poured in disinfection box, pick medicine with swab stick, evenly be applied in desired location.
Embodiment 2
The raw material of effective ingredient of the present invention forms and weight is:
Folium et Ramulus Callicarpae nudiflorae 75g Cortex Magnoliae Officinalis 75g Rhizoma seu Herba Elatostematis stewardii 83g Flos Lonicerae 78g
Ganoderma 17g Folium Aloe 62g Radix Angelicae Pubescentis 71g Radix Zanthoxyli 65g
Herba Portulacae 55g Herba Taraxaci 70g Semen Euphorbiae 55g Herba Artemisiae Annuae 55g
Olibanum 45g Radix Malvae rotundifoliae 55g Radix embeliae laetae 65g Cortex Ailanthi 60g.
Process for preparing medicine processing step and the usage and dosage of the present embodiment are identical with embodiment 1.
Embodiment 3
The raw material of effective ingredient of the present invention forms and weight is:
Folium et Ramulus Callicarpae nudiflorae 65g Cortex Magnoliae Officinalis 65g Rhizoma seu Herba Elatostematis stewardii 75g Flos Lonicerae 69g
Ganoderma 15g Folium Aloe 58g Radix Angelicae Pubescentis 61g Radix Zanthoxyli 55g
Herba Portulacae 50g Herba Taraxaci 60g Semen Euphorbiae 45g Herba Artemisiae Annuae 45g
Olibanum 35g Radix Malvae rotundifoliae 45g Radix embeliae laetae 55g Cortex Ailanthi 50g.
Process for preparing medicine processing step and the usage and dosage of the present embodiment are identical with embodiment 1.
Embodiment 4
The raw material of effective ingredient of the present invention forms and weight is:
Folium et Ramulus Callicarpae nudiflorae 55g Cortex Magnoliae Officinalis 55g Rhizoma seu Herba Elatostematis stewardii 65g Flos Lonicerae 64g
Ganoderma 13g Folium Aloe 50g Radix Angelicae Pubescentis 51g Radix Zanthoxyli 45g
Herba Portulacae 45g Herba Taraxaci 50g Semen Euphorbiae 40g Herba Artemisiae Annuae 35g
Olibanum 25g Radix Malvae rotundifoliae 35g Radix embeliae laetae 45g Cortex Ailanthi 40g.
Process for preparing medicine processing step and the usage and dosage of the present embodiment are identical with embodiment 1.
Clinical data:
1, as clinical laboratory's wound bactericidal antiphlogistic medicine, select traumatic patient 60 examples to carry out clinical use and observe, patient is divided into two groups at random, experimental group 30 examples, matched group 30 examples.
2, treatment group and matched group use respectively medicine of the present invention and iodophor disinfection medicine to carry out bactericidal antiphlogistic to patient's wound.Two groups are all used by the medicine operating instruction.
3, result of use:
The experimental group patient is all without anaphylaxis, and the wound bactericidal antiphlogistic is thorough, without suppurating.
Matched group has 3 people wound suppuration thoroughly not occur because of sterilization, and skin allergy appears in 5 people.
Above result demonstration, the bactericidal anti-inflammatory effect of experimental group is apparently higher than matched group.
Claims (5)
1. clinical laboratory's wound bactericidal antiphlogistic medicine is characterized in that: the raw material of making described effective ingredient forms and parts by weight are:
Folium et Ramulus Callicarpae nudiflorae 45-85 part Cortex Magnoliae Officinalis 50-85 part Rhizoma seu Herba Elatostematis stewardii 60-90 part Flos Lonicerae 60-85 part
Ganoderma 10-20 part Folium Aloe 45-75 part Radix Angelicae Pubescentis 45-80 part Radix Zanthoxyli 35-75 part
Herba Portulacae 40-65 part Herba Taraxaci 40-85 part Semen Euphorbiae 35-65 part Herba Artemisiae Annuae 30-65 part
Olibanum 20-50 part Radix Malvae rotundifoliae 25-65 part Radix embeliae laetae 35-75 part Cortex Ailanthi 35-70 part.
2. a kind of clinical laboratory according to claim 1 wound bactericidal antiphlogistic medicine is characterized in that: the raw material of making described effective ingredient forms and parts by weight are:
78 parts of 83 portions of Flos Loniceraes of 75 parts of Rhizoma seu Herba Elatostematis stewardiis of 75 parts of Cortex Magnoliae Officinalis of Folium et Ramulus Callicarpae nudiflorae
65 parts of 71 portions of Radix Zanthoxylis of 62 parts of Radix Angelicae Pubescentiss of 17 parts of Folium Aloes of Ganoderma
55 parts of 55 portions of Herba Artemisiae Annuaes of 70 parts of Semen Euphorbiaes of 55 parts of Herba Taraxacis of Herba Portulacae
60 parts of 65 parts of Cortex Ailanthis of 55 parts of Radix embeliae laetae of 45 parts of Radix Malvae rotundifoliaes of Olibanum.
3. a kind of clinical laboratory according to claim 1 wound bactericidal antiphlogistic medicine is characterized in that: the raw material of making described effective ingredient forms and parts by weight are:
69 parts of 75 portions of Flos Loniceraes of 65 parts of Rhizoma seu Herba Elatostematis stewardiis of 65 parts of Cortex Magnoliae Officinalis of Folium et Ramulus Callicarpae nudiflorae
55 parts of 61 portions of Radix Zanthoxylis of 58 parts of Radix Angelicae Pubescentiss of 15 parts of Folium Aloes of Ganoderma
45 parts of 45 portions of Herba Artemisiae Annuaes of 60 parts of Semen Euphorbiaes of 50 parts of Herba Taraxacis of Herba Portulacae
50 parts of 55 parts of Cortex Ailanthis of 45 parts of Radix embeliae laetae of 35 parts of Radix Malvae rotundifoliaes of Olibanum.
4. a kind of clinical laboratory according to claim 1 wound bactericidal antiphlogistic medicine is characterized in that: the raw material of making described effective ingredient forms and parts by weight are:
64 parts of 65 portions of Flos Loniceraes of 55 parts of Rhizoma seu Herba Elatostematis stewardiis of 55 parts of Cortex Magnoliae Officinalis of Folium et Ramulus Callicarpae nudiflorae
45 parts of 51 portions of Radix Zanthoxylis of 50 parts of Radix Angelicae Pubescentiss of 13 parts of Folium Aloes of Ganoderma
35 parts of 40 portions of Herba Artemisiae Annuaes of 50 parts of Semen Euphorbiaes of 45 parts of Herba Taraxacis of Herba Portulacae
40 parts of 45 parts of Cortex Ailanthis of 35 parts of Radix embeliae laetae of 25 parts of Radix Malvae rotundifoliaes of Olibanum.
5. preparation method as clinical laboratory's wound bactericidal antiphlogistic medicine as described in claim 1-4 any one is characterized in that: comprise following processing step:
(1) get Folium et Ramulus Callicarpae nudiflorae, Cortex Magnoliae Officinalis, Flos Lonicerae, Herba Taraxaci and Cortex Ailanthi and clean, put into heating vessel, add 85% alcoholic solution of 4 times of amounts, heating and refluxing extraction 3-4 hour, filter, and obtains filtrate for later use;
(2) get Rhizoma seu Herba Elatostematis stewardii, Radix Angelicae Pubescentis, Semen Euphorbiae, Radix Malvae rotundifoliae and Radix embeliae laetae and clean, put into container, the distilled water that adds 8-12 doubly to measure, soaked after 4-5 hour, boils 3-4 hour, extracts; Again add 6-8 doubly to measure distilled water, boil 2-3 hour, extract; Finally, add 4-6 doubly to measure distilled water, heated and boiled 1-2 hour, extract; Merge three times extracting solution, filter, reserved filtrate is standby;
(3) get Herba Portulacae and Herba Artemisiae Annuae and clean, strand juice, filter, and obtains juice standby;
(4) get Olibanum, clean, while with slow fire, frying to surface melting, spray a small amount of rice vinegar, continue to fry to outer light, take out, cool, grind into powder, cross 200 order fine powders, standby;
(5) get Ganoderma, Folium Aloe and Radix Zanthoxyli, cleaning, drying, chopping, grind into powder, crosses 120 order fine powders, and is standby;
(6) filtrate that above-mentioned steps (1)-(5) are made, juice and fine powder mix, and add ancillary drug, utilize modern advanced pharmacy science and technology, make antiseptic solution, are described clinical laboratory wound bactericidal antiphlogistic medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310334996.5A CN103393902B (en) | 2013-08-03 | 2013-08-03 | Clinical-laboratory traumatic bactericidal inflammation-diminishing drug and preparation method thereof, |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310334996.5A CN103393902B (en) | 2013-08-03 | 2013-08-03 | Clinical-laboratory traumatic bactericidal inflammation-diminishing drug and preparation method thereof, |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103393902A true CN103393902A (en) | 2013-11-20 |
| CN103393902B CN103393902B (en) | 2014-10-29 |
Family
ID=49557755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310334996.5A Expired - Fee Related CN103393902B (en) | 2013-08-03 | 2013-08-03 | Clinical-laboratory traumatic bactericidal inflammation-diminishing drug and preparation method thereof, |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103393902B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103814968A (en) * | 2014-03-20 | 2014-05-28 | 郭目勇 | Drug for sterilizing anaesthesia operating room |
| CN104510821A (en) * | 2014-08-27 | 2015-04-15 | 赵鑫 | Anesthesiology sponge with sterilizing and inflammation eliminating efficacies, and production method thereof |
| CN104666586A (en) * | 2015-03-30 | 2015-06-03 | 井绪菊 | Nursing powder for disinfecting wound of person with infectious disease and preparation method of nursing powder |
| CN104815077A (en) * | 2015-05-13 | 2015-08-05 | 张鑫 | Bactericidal and anti-inflammatory substance for treating clinical laboratory trauma and preparation method thereof |
| CN105535476A (en) * | 2015-12-21 | 2016-05-04 | 张学军 | Clinical laboratory traumatic bactericidal anti-inflammation medicament and preparation method thereof, |
| CN105663812A (en) * | 2015-12-31 | 2016-06-15 | 刘婵琳 | Traditional Chinese medicinal anti-inflammatory and antibacterial liquid for nursing |
| CN105746606A (en) * | 2016-02-22 | 2016-07-13 | 李向红 | Clinical laboratory indoor disinfector and preparation method thereof |
| CN106070386A (en) * | 2016-06-29 | 2016-11-09 | 杨莉 | The Chinese medicine liquid medicine of a kind of control laboratory sterilizing and preparation method |
| CN106818942A (en) * | 2017-02-28 | 2017-06-13 | 殷雪华 | A kind of Hospital Infection-Control Dept. sterilizing Chinese medicine composition |
| CN115737702A (en) * | 2022-12-13 | 2023-03-07 | 大连鸿德中药养生有限公司 | Snake venom anti-inflammatory medicine and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433590A (en) * | 2008-12-01 | 2009-05-20 | 衣真颉 | Chinese medicine for treating skin erosion and pruritus and preparation method thereof |
| CN103202981A (en) * | 2013-05-08 | 2013-07-17 | 山东新希望六和集团有限公司 | Medicine for treating trauma infectious diseases of animals |
| CN103223061A (en) * | 2013-04-28 | 2013-07-31 | 秦晓飞 | External application bedsore drug and preparation method thereof |
-
2013
- 2013-08-03 CN CN201310334996.5A patent/CN103393902B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433590A (en) * | 2008-12-01 | 2009-05-20 | 衣真颉 | Chinese medicine for treating skin erosion and pruritus and preparation method thereof |
| CN103223061A (en) * | 2013-04-28 | 2013-07-31 | 秦晓飞 | External application bedsore drug and preparation method thereof |
| CN103202981A (en) * | 2013-05-08 | 2013-07-17 | 山东新希望六和集团有限公司 | Medicine for treating trauma infectious diseases of animals |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103814968A (en) * | 2014-03-20 | 2014-05-28 | 郭目勇 | Drug for sterilizing anaesthesia operating room |
| CN103814968B (en) * | 2014-03-20 | 2015-07-01 | 周庆华 | Drug for sterilizing anaesthesia operating room |
| CN104510821A (en) * | 2014-08-27 | 2015-04-15 | 赵鑫 | Anesthesiology sponge with sterilizing and inflammation eliminating efficacies, and production method thereof |
| CN104666586A (en) * | 2015-03-30 | 2015-06-03 | 井绪菊 | Nursing powder for disinfecting wound of person with infectious disease and preparation method of nursing powder |
| CN104815077A (en) * | 2015-05-13 | 2015-08-05 | 张鑫 | Bactericidal and anti-inflammatory substance for treating clinical laboratory trauma and preparation method thereof |
| CN105535476A (en) * | 2015-12-21 | 2016-05-04 | 张学军 | Clinical laboratory traumatic bactericidal anti-inflammation medicament and preparation method thereof, |
| CN105663812A (en) * | 2015-12-31 | 2016-06-15 | 刘婵琳 | Traditional Chinese medicinal anti-inflammatory and antibacterial liquid for nursing |
| CN105746606A (en) * | 2016-02-22 | 2016-07-13 | 李向红 | Clinical laboratory indoor disinfector and preparation method thereof |
| CN106070386A (en) * | 2016-06-29 | 2016-11-09 | 杨莉 | The Chinese medicine liquid medicine of a kind of control laboratory sterilizing and preparation method |
| CN106818942A (en) * | 2017-02-28 | 2017-06-13 | 殷雪华 | A kind of Hospital Infection-Control Dept. sterilizing Chinese medicine composition |
| CN115737702A (en) * | 2022-12-13 | 2023-03-07 | 大连鸿德中药养生有限公司 | Snake venom anti-inflammatory medicine and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103393902B (en) | 2014-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393902B (en) | Clinical-laboratory traumatic bactericidal inflammation-diminishing drug and preparation method thereof, | |
| CN101590153A (en) | Compound skin comfort liquid | |
| CN103393953A (en) | Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof | |
| CN101791378B (en) | Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration | |
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN102266441B (en) | Chinese medicinal ointment for treating burns and scalds | |
| CN104689066A (en) | Traditional Chinese medicine composition for treating burns and preparation method thereof | |
| CN104288504A (en) | Traditional Chinese medicinal ointment preparation for treating burn and scalds and preparation method thereof | |
| CN102357164B (en) | Medicine composition for clinical care of burns and preparation method thereof | |
| CN104491107A (en) | Traditional Chinese medicine preparation for treating burns and preparation method thereof | |
| CN101966250A (en) | Externally applied Chinese medicament for treating burn and manufacturing method thereof | |
| CN101244109A (en) | Natural Chinese medicine of oil-water liniment for treating burn and scald, and preparation thereof | |
| CN103191307B (en) | Herbal ointment for treating cauterization and scald and preparation method of herbal ointment | |
| CN102846782A (en) | External traditional Chinese medicine ointment for treating burns and scalds and preparation method thereof | |
| CN104274662A (en) | Itching treating medicine | |
| CN110538249B (en) | Scorpion-astragalus dermatitis liquid medicine | |
| CN105943778A (en) | Traditional Chinese medicine composition for treating burns and scalds and preparation method thereof | |
| CN106728069B (en) | Slough-removing and tissue regeneration-promoting paste for treating scalds and burns | |
| CN104958757A (en) | Pressure sore paste and preparation method thereof | |
| CN103599377A (en) | Traditional Chinese medicine for treating burn | |
| CN103520687A (en) | Bath foot powder for inhibiting fungi | |
| CN102847019A (en) | Chinese medicinal ointment for treating burns and scalds and preparation method thereof | |
| CN108498649B (en) | Scorpion-astragalus root ointment | |
| CN106902213B (en) | Formula and preparation method of externally-used traditional Chinese medicine ointment for treating acne, furuncle and sore | |
| CN108245577B (en) | Ointment for relieving pain, eliminating swelling and promoting tissue regeneration of burn and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141029 Termination date: 20150803 |
|
| EXPY | Termination of patent right or utility model |